PolyPid
PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).
PolyPid has raised €44M across 1 funding round, most recently a Series D+ round in Jul 2019. Based in Petah Tiqva, Israel; founded 2008; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€44M
€43,936,731
Funding rounds
1
Investors
0
distinct backers
Active since
2019-07
latest 2019-07
Funding by year
EUR raised per yearPolyPid — funding by year — interactive chart.
Data table
| PolyPid — funding by year | |
|---|---|
| 2019 | €44M |
Signals
Medium confidenceRaise-next likelihood11
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series D+ | €44M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData